Added value of end of life and orphan medicines: a thematic analysis from the patient/carer perspective

Jan Jones; Eileen Harkess-Murphy; Lindsay Lockhart; Anne Lee; Jonathan Fox; Ailsa Brown

Added value of end of life and orphan medicines: a thematic analysis from the patient/carer perspective

Jan Jones, Eileen Harkess-Murphy, Lindsay Lockhart, Anne Lee, Jonathan Fox, Ailsa Brown (Contributor)

Research output: Contribution to conference › Poster

Abstract

The Scottish Medicines Consortium advises NHS Scotland on the clinical and cost-effectiveness of new medicines. Recent process changes have given patients and clinicians a stronger voice in decisions for end of life and orphan medicines. Thematic analysis of information provided by patients and carers has improved our understanding of the key factors that are important to patients.

Original language	English
Publication status	Published - 10 May 2016
Externally published	Yes
Event	HTAi 2016 Annual Meeting : Informing Health Care Decisions with Values and Evidence - Keio Plaza Hotel, Tokyo, Japan Duration: 10 May 2016 → 14 May 2016 http://meeting.htai.org/events/tokyo2016/event-summary-4023afce0ec04ab387500e87f0a6a42d.aspx (Conference website)

Conference

Conference	HTAi 2016 Annual Meeting
Abbreviated title	HTAi 2016
Country/Territory	Japan
City	Tokyo
Period	10/05/16 → 14/05/16
Internet address	http://meeting.htai.org/events/tokyo2016/event-summary-4023afce0ec04ab387500e87f0a6a42d.aspx (Conference website)

Cite this

@conference{20297e100d5649b98bf4b2a5558efb7f,

title = "Added value of end of life and orphan medicines: a thematic analysis from the patient/carer perspective",

abstract = "The Scottish Medicines Consortium advises NHS Scotland on the clinical and cost-effectiveness of new medicines. Recent process changes have given patients and clinicians a stronger voice in decisions for end of life and orphan medicines. Thematic analysis of information provided by patients and carers has improved our understanding of the key factors that are important to patients.",

author = "Jan Jones and Eileen Harkess-Murphy and Lindsay Lockhart and Anne Lee and Jonathan Fox and Ailsa Brown",

note = "Poster presented at conference by Ailsa Brown.; HTAi 2016 Annual Meeting : Informing Health Care Decisions with Values and Evidence, HTAi 2016 ; Conference date: 10-05-2016 Through 14-05-2016",

year = "2016",

month = may,

day = "10",

language = "English",

url = "http://meeting.htai.org/events/tokyo2016/event-summary-4023afce0ec04ab387500e87f0a6a42d.aspx",

}

TY - CONF

T1 - Added value of end of life and orphan medicines

T2 - HTAi 2016 Annual Meeting

AU - Jones, Jan

AU - Harkess-Murphy, Eileen

AU - Lockhart, Lindsay

AU - Lee, Anne

AU - Fox, Jonathan

A2 - Brown, Ailsa

N1 - Poster presented at conference by Ailsa Brown.

PY - 2016/5/10

Y1 - 2016/5/10

N2 - The Scottish Medicines Consortium advises NHS Scotland on the clinical and cost-effectiveness of new medicines. Recent process changes have given patients and clinicians a stronger voice in decisions for end of life and orphan medicines. Thematic analysis of information provided by patients and carers has improved our understanding of the key factors that are important to patients.

AB - The Scottish Medicines Consortium advises NHS Scotland on the clinical and cost-effectiveness of new medicines. Recent process changes have given patients and clinicians a stronger voice in decisions for end of life and orphan medicines. Thematic analysis of information provided by patients and carers has improved our understanding of the key factors that are important to patients.

UR - http://meeting.htai.org/events/tokyo2016/agenda-4023afce0ec04ab387500e87f0a6a42d.aspx

M3 - Poster

Y2 - 10 May 2016 through 14 May 2016

ER -

Added value of end of life and orphan medicines: a thematic analysis from the patient/carer perspective

Abstract

Conference

Other files and links

Fingerprint

Cite this